Yes, glucagon is still used, although limitations exist regarding its traditional formulations.
While newer, more stable formulations of glucagon (like nasal and pre-filled options) are increasingly available, traditional glucagon formulations that require reconstitution before injection are still used, particularly in countries where these newer formulations are not readily accessible. The shelf life and complexity of reconstitution are drawbacks to the older formulations, but they remain a viable option in many parts of the world for treating severe hypoglycemia.